Loading...
Loading...
ARAY| Name | Value |
|---|---|
| Revenues | 101.1M |
| Cost of Revenue | 72.1M |
| Gross Profit | 29.1M |
| Operating Expense | 33.6M |
| Operating I/L | -4.6M |
| Other Income/Expense | -1.3M |
| Interest Income | 2.6M |
| Pretax | -5.9M |
| Income Tax Expense | 0.4M |
| Net Income/Loss | -6.3M |
Accuray Incorporated specializes in the design, development, manufacturing, and sale of radiosurgery and radiation therapy systems for tumor treatment. Their flagship products include the CyberKnife System, a robotic stereotactic radiosurgery and body radiation therapy system, and the TomoTherapy System, designed for a range of cancer types. The company also provides post-contract customer support, installation, training, and professional services. Accuray primarily markets its products directly to hospitals and treatment facilities, as well as through distributors and sales agents internationally.
